×
About 17,150 results

ALLMedicine™ Adenovirus Center

Research & Reviews  6,004 results

Sensitivity of Detection and Variant Typing of SARS-CoV-2 in European Laboratories.
https://doi.org/10.1128/jcm.01261-22
Journal of Clinical Microbiology; Mögling R, Fischer C et. al.

Nov 30th, 2022 - The molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is key for clinical management and surveillance. Funded by the European Centre for Disease Prevention and Control, we conducted an external quality assessment ...

Oncolytic Viruses and Cancer Immunotherapy.
https://doi.org/10.1007/s11912-022-01341-w
Current Oncology Reports; Malhotra J, Kim ES

Nov 29th, 2022 - Oncolytic viruses (OVs) exert their antitumor effect through selective killing of cancer cells and induction of host anti-tumor immunity. This review aims to summarize the recent and current trials with OVs for the treatment of lung cancer. Severa...

Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the effi...
https://doi.org/10.1007/s00262-022-03334-x
Cancer Immunology, Immunotherapy : CII; Kajiwara Y, Tazawa H et. al.

Nov 28th, 2022 - Pancreatic ductal adenocarcinoma (PDAC) is often refractory to treatment with gemcitabine (GEM) and immune checkpoint inhibitors including anti-programmed cell death ligand 1 (PD-L1) antibody. However, the precise relationship between GEM-resistan...

Acute retinal necrosis: clinical features, management and outcomes.
https://doi.org/10.1007/s10792-022-02598-7
International Ophthalmology; Ozdemir Yalcinsoy K, Cakar Ozdal P et. al.

Nov 28th, 2022 - To evaluate the clinical features, treatment, and visual outcome of patients with acute retinal necrosis (ARN). The data of patients were retrospectively reviewed. Factors associated with visual loss and factors affecting the risk for retinal deta...

The Pathologic Spectrum of Adenovirus Nephritis in the Kidney Allograft.
https://doi.org/10.1016/j.kint.2022.10.025
Kidney International; Jagannathan G, Weins A et. al.

Nov 28th, 2022 - Adenovirus nephritis (ADVN) is a rare and understudied complication of kidney transplantation. Unlike BK virus nephropathy (BKVN), our knowledge of clinicopathologic manifestations of ADVN remains rudimentary and essentially limited to case report...

see more →

Guidelines  1 results

Community acquired respiratory virus infections in cancer patients-Guideline on diagnos...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125955
European Journal of Cancer (Oxford, England : 1990); von Lilienfeld-Toal M, Berger A et. al.

Sep 30th, 2016 - Community acquired viruses (CRVs) may cause severe disease in cancer patients. Thus, efforts should be made to diagnose CRV rapidly and manage CRV infections accordingly. A panel of 18 clinicians from the Infectious Diseases Working Party of the G...

see more →

Drugs  15 results see all →

Clinicaltrials.gov  404 results

Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5
https://clinicaltrials.gov/ct2/show/NCT03520712

Oct 14th, 2022 - This study is being conducted by BioMarin Pharmaceutical Inc. as an open label, single dose study to determine the safety of valoctocogene roxaparvovec (an Adenovirus-Associated Virus (AAV) based gene therapy vector) in severe Hemophilia A patient...

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials
https://clinicaltrials.gov/ct2/show/NCT02315599

Oct 14th, 2022 - Background: Study subjects exposed to gene therapy interventions may be at risk for delayed or longterm adverse consequences. The U.S. Food and Drug Administration (FDA) has issued Long Term Follow-up After Administration of Human Gene Therapy Pro...

Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
https://clinicaltrials.gov/ct2/show/NCT05284097

Oct 14th, 2022 - This study is being conducted to assess the safety and immunogenicity of the Ad26.ZEBOV (Dose 1), MVA-BN-Filo (Dose 2) vaccine regimen, administered with a 56-day interval between the two doses, in adults and children previously enrolled in the co...

Gene Therapy Study in Severe Haemophilia A Patients (270-201)
https://clinicaltrials.gov/ct2/show/NCT02576795

Oct 14th, 2022 - This study is being conducted by BioMarin Pharmaceutical Inc. as an open label, dose escalation study in order to determine the safety and efficacy of valoctocogene roxaparvovec (an Adenovirus-Associated Virus based gene therapy vector in particip...

Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol
https://clinicaltrials.gov/ct2/show/NCT05094609

Oct 12th, 2022 - This is a phase 1, dose-escalating study to evaluate the safety and immunogenicity of a single dose of either Ad5-triCoV/Mac, a replication deficient human adenovirus vector, or ChAd-triCoV/Mac, a replication deficient chimpanzee adenovirus 68 vec...

see more →

News  425 results

Sick Call
https://www.medscape.com/viewarticle/984535

Nov 23rd, 2022 - They call me and I go. – William Carlos Williams I never get sick. I've never had the flu. When everyone's got a cold, I'm somehow immune. The last time I threw up was June 29th, 1980. You see, I work out almost daily, eat vegan, and sleep plenty....

Most Pediatric Myocarditis Caused by Viruses
https://www.medscape.com/viewarticle/982609

Oct 18th, 2022 - ANAHEIM — A wide range of factors can cause myocarditis; most often viral infections cause myocarditis in children and teens, according to Ryan Butts, MD, medical director of the pediatric advanced cardiac care program at the University of Texas S...

EMA Grants Orphan Drug Designation to CAN-2409 for Glioma
https://www.onclive.com/view/ema-grants-orphan-drug-designation-to-can-2409-for-glioma

Sep 16th, 2022 - The European Medicines Agency (EMA) Committee for Orphan Medical Products has granted an orphan drug designation (ODD) to CAN-2409 for the treatment of patients with glioma, according to an announcement from Candel Therapeutics.1 CAN-2409 is a ...

China, India Approve Nasal COVID Vaccines
https://www.medscape.com/viewarticle/980366

Sep 7th, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. China and India have approved COVID-19 vaccines that can be given through the nose or mouth, which scientists hope will be a "game changer" for th...

CanSino's Inhaled COVID-19 Vaccine Gets Emergency Use Approval in China
https://www.medscape.com/viewarticle/980221

Sep 6th, 2022 - HONG KONG (Reuters) - China's CanSino Biologics Inc said on Sunday that its recently developed COVID-19 vaccine has been approved by the country's drug regulator for emergency use as a booster, potentially benefiting its business. The inhaled vers...

see more →

Patient Education  11 results see all →